Author: Terpening C. Gums J.G. Grauer K.
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.1, Iss.1, 1999-11, pp. : 71-80
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Hypertension, in spite of a very high prevalence, remains undertreated. This is not due to a lack of effective therapeutic modalities. Non-pharmacological treatments can be effective in many patients. If those treatments fail to reduce blood pressure sufficiently, the physician can choose between numerous classes of antihypertensive agents. However, interpatient variability in response to these agents is high, and use of multiple agents is frequently necessary. Thus, no single class has proven to be superior for the majority of patients. This article will review the different non-pharmacological and pharmacological methods available to treat hypertension, as well as the guidelines that are available to aid in proper selection of a treatment regimen.
Related content
Nebivolol in the Management of Essential Hypertension: A Review
Drugs, Vol. 57, Iss. 4, 1999-04 ,pp. :
Moexipril: A Review of its Use in the Management of Essential Hypertension
Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. :
Vascular Abnormalities in Essential Hypertension
Current Pharmaceutical Design, Vol. 17, Iss. 28, 2011-09 ,pp. :
Inflammation Markers in Essential Hypertension
Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. :
Oxidative Stress in Essential Hypertension
Current Pharmaceutical Design, Vol. 10, Iss. 14, 2004-05 ,pp. :